Implementation and evaluation of a docking-rescoring method using molecular footprint comparisons
|
journal
|
May 2011 |
SPFP: Speed without compromise—A mixed precision model for GPU accelerated molecular dynamics simulations
|
journal
|
February 2013 |
Docking Screens for Novel Ligands Conferring New Biology: Miniperspective
|
journal
|
March 2016 |
Phantom PAINS: Problems with the Utility of Alerts for P an- A ssay IN terference Compound S
|
journal
|
February 2017 |
Footprint-based identification of viral entry inhibitors targeting HIVgp41
|
journal
|
April 2012 |
Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation
|
journal
|
October 2002 |
Toremifene interacts with and destabilizes the Ebola virus glycoprotein
|
journal
|
June 2016 |
The Ecstasy and Agony of Assay Interference Compounds
|
journal
|
February 2017 |
Permanent Inhibition of Viral Entry by Covalent Entrapment of HIV gp41 on the Virus Surface
|
journal
|
August 2011 |
Small molecule inhibitors of HIVgp41 N-heptad repeat trimer formation
|
journal
|
July 2015 |
Characteristics and survival of patients with Ebola virus infection, malaria, or both in Sierra Leone: a retrospective cohort study
|
journal
|
June 2017 |
Design, Synthesis, and Structure−Activity Relationship of a Novel Series of 2-Aryl 5-(4-Oxo-3-phenethyl-2-thioxothiazolidinylidenemethyl)furans as HIV-1 Entry Inhibitors ⊥
|
journal
|
December 2009 |
Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection
|
journal
|
June 2005 |
Ebola Virus Enters Host Cells by Macropinocytosis and Clathrin-Mediated Endocytosis
|
journal
|
November 2011 |
Comparison of simple potential functions for simulating liquid water
|
journal
|
July 1983 |
Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald
|
journal
|
August 2013 |
DOCK 6: Impact of new features and current docking performance
|
journal
|
April 2015 |
Novel Small Molecule Entry Inhibitors of Ebola Virus
|
journal
|
July 2015 |
Structure-based identification of inhibitors targeting obstruction of the HIVgp41 N-heptad repeat trimer
|
journal
|
July 2017 |
Computer-Aided Approaches for Targeting HIVgp41
|
journal
|
August 2012 |
Ebola virus entry requires the cholesterol transporter Niemann–Pick C1
|
journal
|
August 2011 |
ZINC ? A Free Database of Commercially Available Compounds for Virtual Screening.
|
journal
|
April 2005 |
Identification of Ellagic Acid from Plant Rhodiola rosea L. as an Anti-Ebola Virus Entry Inhibitor
|
journal
|
March 2018 |
Clomiphene and Its Isomers Block Ebola Virus Particle Entry and Infection with Similar Potency: Potential Therapeutic Implications
|
journal
|
August 2016 |
The Ecstasy and Agony of Assay Interference Compounds
|
journal
|
February 2017 |
C-peptide inhibitors of Ebola virus glycoprotein-mediated cell entry: Effects of conjugation to cholesterol and side chain–side chain crosslinking
|
journal
|
October 2013 |
Chemical and Structural Aspects of Ebola Virus Entry Inhibitors
|
journal
|
December 2014 |
Automated docking with grid-based energy evaluation
|
journal
|
May 1992 |
Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target
|
journal
|
December 1998 |
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
|
journal
|
March 2017 |
Implementation of the Hungarian Algorithm to Account for Ligand Symmetry and Similarity in Structure-Based Design
|
journal
|
January 2014 |
UCSF Chimera?A visualization system for exploratory research and analysis
|
journal
|
January 2004 |
Identification of a Small-Molecule Entry Inhibitor for Filoviruses
|
journal
|
January 2011 |
Development of Indole Compounds as Small Molecule Fusion Inhibitors Targeting HIV-1 Glycoprotein-41
|
journal
|
October 2011 |
Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolution
|
journal
|
March 1999 |
Basic Clinical and Laboratory Features of Filoviral Hemorrhagic Fever
|
journal
|
November 2011 |
Ebola Virus and Severe Acute Respiratory Syndrome Coronavirus Display Late Cell Entry Kinetics: Evidence that Transport to NPC1 + Endolysosomes Is a Rate-Defining Step
|
journal
|
December 2014 |
Identification of Combinations of Approved Drugs With Synergistic Activity Against Ebola Virus in Cell Cultures
|
journal
|
June 2018 |
Potent neutralizing monoclonal antibodies against Ebola virus infection
|
journal
|
May 2016 |
Fifteen countries are at risk of Ebola outbreak, says WHO
|
journal
|
October 2014 |
Designed protein mimics of the Ebola virus glycoprotein GP2 α-helical bundle: Stability and pH effects
|
journal
|
August 2011 |
Inhibition of Ebola Virus Entry by a C-peptide Targeted to Endosomes
|
journal
|
March 2011 |
Ebola Virus Entry: A Curious and Complex Series of Events
|
journal
|
April 2015 |
Strategies for lead discovery: Application of footprint similarity targeting HIVgp41
|
journal
|
January 2014 |
Development of therapeutics for treatment of Ebola virus infection
|
journal
|
February 2015 |
COBALT: constraint-based alignment tool for multiple protein sequences
|
journal
|
March 2007 |
Biochemical and Functional Characterization of the Ebola Virus VP24 Protein: Implications for a Role in Virus Assembly and Budding
|
journal
|
February 2003 |
Enfuvirtide
|
journal
|
May 2003 |
ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB
|
journal
|
July 2015 |
Structural Insights into the Niemann-Pick C1 (NPC1)-Mediated Cholesterol Transfer and Ebola Infection
|
journal
|
June 2016 |
Development of HIV Entry Inhibitors Targeted to the Coiled-Coil Regions of gp41
|
journal
|
March 2000 |
Molecular docking based screening of predicted potential inhibitors for VP40 from Ebola virus [English]
|
journal
|
May 2015 |
The Intracellular Cargo Receptor ERGIC-53 Is Required for the Production of Infectious Arenavirus, Coronavirus, and Filovirus Particles
|
journal
|
November 2013 |
C-peptide inhibitors of Ebola virus glycoprotein-mediated cell entry: Effects of conjugation to cholesterol and side chain–side chain crosslinking
|
journal
|
October 2013 |
Development of therapeutics for treatment of Ebola virus infection
|
journal
|
February 2015 |
pH-REMD Simulations Indicate That the Catalytic Aspartates of HIV-1 Protease Exist Primarily in a Monoprotonated State
|
journal
|
October 2014 |
Development of Small-molecule HIV Entry Inhibitors Specifically Targeting gp120 or gp41
|
journal
|
December 2015 |
Strategies for lead discovery: Application of footprint similarity targeting HIVgp41
|
journal
|
January 2014 |
Novel cyclo-peptides inhibit Ebola pseudotyped virus entry by targeting primed GP protein
|
journal
|
July 2018 |
Basic local alignment search tool
|
journal
|
October 1990 |
PubChem BioAssay: 2017 update
|
journal
|
November 2016 |
An Aggregation Advisor for Ligand Discovery
|
journal
|
August 2015 |
FAF-Drugs3: a web server for compound property calculation and chemical library design
|
journal
|
April 2015 |
In silico prediction of Ebola Zaire GP1,2 immuno-dominant epitopes for the Balb/c mouse
|
journal
|
October 2015 |
Mechanism of high-mannose N-glycan breakdown and metabolism by Bifidobacterium longum
|
journal
|
November 2022 |
Implementation of the Hungarian Algorithm to Account for Ligand Symmetry and Similarity in Structure-Based Design
|
journal
|
January 2014 |
PubChem Substance and Compound databases
|
journal
|
September 2015 |
Inhibition of HIV Entry by Targeting the Envelope Transmembrane Subunit gp41
|
journal
|
March 2016 |
Design, Synthesis, and Structure−Activity Relationship of a Novel Series of 2-Aryl 5-(4-Oxo-3-phenethyl-2-thioxothiazolidinylidenemethyl)furans as HIV-1 Entry Inhibitors ⊥
|
journal
|
December 2009 |
Grid-based molecular footprint comparison method for docking and de novo design: Application to HIVgp41
|
journal
|
February 2013 |
Pharmacophore-Based Similarity Scoring for DOCK
|
journal
|
August 2014 |
VMD: Visual molecular dynamics
|
journal
|
February 1996 |
PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data
|
journal
|
June 2013 |
Docking Screens for Novel Ligands Conferring New Biology: Miniperspective
|
journal
|
March 2016 |
Implementation and evaluation of a docking-rescoring method using molecular footprint comparisons
|
journal
|
May 2011 |
Phantom PAINS: Problems with the Utility of Alerts for P an- A ssay IN terference Compound S
|
journal
|
February 2017 |
Identification of small molecule inhibitors of botulinum neurotoxin serotype E via footprint similarity
|
journal
|
October 2016 |
High mortality in non-Ebola virus disease cases: need to provide timely and effective care
|
journal
|
October 2017 |
The Primed Ebolavirus Glycoprotein (19-Kilodalton GP1,2): Sequence and Residues Critical for Host Cell Binding
|
journal
|
January 2009 |
Basic Clinical and Laboratory Features of Filoviral Hemorrhagic Fever
|
journal
|
November 2011 |
Footprint-based identification of viral entry inhibitors targeting HIVgp41
|
journal
|
April 2012 |
Permanent Inhibition of Viral Entry by Covalent Entrapment of HIV gp41 on the Virus Surface
|
journal
|
August 2011 |
Small molecule inhibitors of HIVgp41 N-heptad repeat trimer formation
|
journal
|
July 2015 |
Small molecule inhibitors reveal Niemann–Pick C1 is essential for Ebola virus infection
|
journal
|
August 2011 |
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
|
journal
|
April 2010 |
Development of Peptide and Small-Molecule HIV-1 Fusion Inhibitors that Target gp41
|
journal
|
September 2010 |
Docking Validation Resources: Protein Family and Ligand Flexibility Experiments
|
journal
|
October 2010 |
Grid-based molecular footprint comparison method for docking and de novo design: Application to HIVgp41
|
journal
|
February 2013 |
Clinical Management of Ebola Virus Disease in the United States and Europe
|
journal
|
February 2016 |
Mapping of Ebolavirus Neutralization by Monoclonal Antibodies in the ZMapp Cocktail Using Cryo-Electron Tomography and Studies of Cellular Entry
|
journal
|
June 2016 |
Biological weapons: Bioterrorism: management of major biological agents
|
journal
|
September 2006 |
Ebola virus entry requires the cholesterol transporter Niemann–Pick C1
|
journal
|
August 2011 |
Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity
|
journal
|
November 1995 |
Structure-based identification of inhibitors targeting obstruction of the HIVgp41 N-heptad repeat trimer
|
journal
|
July 2017 |
Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists
|
journal
|
July 2015 |
Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 1. Generalized Born
|
journal
|
April 2012 |
ZINC − A Free Database of Commercially Available Compounds for Virtual Screening
|
journal
|
December 2004 |
A new player in the puzzle of filovirus entry
|
journal
|
April 2012 |
Vesicular Stomatitis Virus G Protein Acquires pH-Independent Fusion Activity during Transport in a Polarized Endometrial Cell Line
|
journal
|
December 1999 |
Identification of Ellagic Acid from Plant Rhodiola rosea L. as an Anti-Ebola Virus Entry Inhibitor
|
journal
|
March 2018 |
Comparison of multiple Amber force fields and development of improved protein backbone parameters
|
journal
|
November 2006 |
Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection
|
journal
|
June 2005 |
Development and testing of a general amber force field
|
journal
|
January 2004 |
Target Identification and Mode of Action of Four Chemically Divergent Drugs against Ebolavirus Infection
|
journal
|
January 2018 |
Using shape complementarity as an initial screen in designing ligands for a receptor binding site of known three-dimensional structure
|
journal
|
April 1988 |
Toremifene interacts with and destabilizes the Ebola virus glycoprotein
|
journal
|
June 2016 |
Molecular docking based screening of predicted potential inhibitors for VP40 from Ebola virus [English]
|
journal
|
May 2015 |
Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation
|
journal
|
October 2002 |
Ebola Virus Disease in West Africa — Clinical Manifestations and Management
|
journal
|
November 2014 |
Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald
|
journal
|
August 2013 |
Comparison of simple potential functions for simulating liquid water
|
journal
|
July 1983 |
A Novel Life Cycle Modeling System for Ebola Virus Shows a Genome Length-Dependent Role of VP24 in Virus Infectivity
|
journal
|
June 2014 |
Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses
|
journal
|
October 2015 |
Ebola Virus Entry: A Curious and Complex Series of Events
|
journal
|
April 2015 |
Structure-Based Identification of Small Molecule Antiviral Compounds Targeted to the gp41 Core Structure of the Human Immunodeficiency Virus Type 1
|
journal
|
August 1999 |
Stepwise gating of the Sec61 protein-conducting channel by Sec63 and Sec62
|
journal
|
January 2021 |
Design and characterization of ebolavirus GP prehairpin intermediate mimics as drug targets: Designed Ebolavirus Prehairpin Intermediate Mimics
|
journal
|
October 2014 |
An Aggregation Advisor for Ligand Discovery
|
journal
|
August 2015 |
Identification of Combinations of Approved Drugs With Synergistic Activity Against Ebola Virus in Cell Cultures
|
journal
|
June 2018 |
Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies
|
journal
|
August 2015 |
Novel cyclo-peptides inhibit Ebola pseudotyped virus entry by targeting primed GP protein
|
journal
|
July 2018 |
Emergence of Zaire Ebola Virus Disease in Guinea
|
journal
|
October 2014 |
Structural Insights into the Niemann-Pick C1 (NPC1)-Mediated Cholesterol Transfer and Ebola Infection
|
journal
|
June 2016 |
Potent neutralizing monoclonal antibodies against Ebola virus infection
|
journal
|
May 2016 |
Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding Site
|
journal
|
May 2016 |
Automated docking with grid-based energy evaluation
|
journal
|
May 1992 |
Transient Mammalian Cell Transfection with Polyethylenimine (PEI)
|
book
|
January 2013 |
Enfuvirtide
|
journal
|
May 2003 |
Chemical and Structural Aspects of Ebola Virus Entry Inhibitors
|
journal
|
December 2014 |
COBALT: constraint-based alignment tool for multiple protein sequences
|
journal
|
March 2007 |
PubChem Substance and Compound databases
|
journal
|
September 2015 |
Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target
|
journal
|
December 1998 |
Using shape complementarity as an initial screen in designing ligands for a receptor binding site of known three-dimensional structure
|
journal
|
April 1988 |
Clomiphene and Its Isomers Block Ebola Virus Particle Entry and Infection with Similar Potency: Potential Therapeutic Implications
|
journal
|
August 2016 |
Target Identification and Mode of Action of Four Chemically Divergent Drugs against Ebolavirus Infection
|
journal
|
January 2018 |
Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors
|
journal
|
March 2009 |
Pharmacophore-Based Similarity Scoring for DOCK
|
journal
|
August 2014 |
Design and characterization of ebolavirus GP prehairpin intermediate mimics as drug targets: Designed Ebolavirus Prehairpin Intermediate Mimics
|
journal
|
October 2014 |
Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolution
|
journal
|
March 1999 |
Inhibition of heat-shock protein 90 reduces Ebola virus replication
|
journal
|
August 2010 |
Development of Indole Compounds as Small Molecule Fusion Inhibitors Targeting HIV-1 Glycoprotein-41
|
journal
|
October 2011 |
DOCK 6: Impact of new features and current docking performance
|
journal
|
April 2015 |
Computer-Aided Approaches for Targeting HIVgp41
|
journal
|
August 2012 |
N-Substituted Pyrrole Derivatives as Novel Human Immunodeficiency Virus Type 1 Entry Inhibitors That Interfere with the gp41 Six-Helix Bundle Formation and Block Virus Fusion
|
journal
|
October 2004 |
Optimization of lentiviral vector production using polyethylenimine-mediated transfection
|
journal
|
November 2014 |
Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM
|
journal
|
January 2015 |
Identification of Diaryl-Quinoline Compounds as Entry Inhibitors of Ebola Virus
|
journal
|
November 2018 |
Proteolysis of the Ebola Virus Glycoproteins Enhances Virus Binding and Infectivity
|
journal
|
October 2007 |
FAF-Drugs3: a web server for compound property calculation and chemical library design
|
journal
|
April 2015 |
Docking Validation Resources: Protein Family and Ligand Flexibility Experiments
|
journal
|
October 2010 |
Ebolavirus glycoprotein structure and mechanism of entry
|
journal
|
November 2009 |
Cysteine Cathepsin Inhibitors as Anti-Ebola Agents
|
journal
|
February 2016 |
Development of Peptide and Small-Molecule HIV-1 Fusion Inhibitors that Target gp41
|
journal
|
September 2010 |
Development of HIV Entry Inhibitors Targeted to the Coiled-Coil Regions of gp41
|
journal
|
March 2000 |
The Intracellular Cargo Receptor ERGIC-53 Is Required for the Production of Infectious Arenavirus, Coronavirus, and Filovirus Particles
|
journal
|
November 2013 |
Ebola Virus Enters Host Cells by Macropinocytosis and Clathrin-Mediated Endocytosis
|
journal
|
November 2011 |
PubChem BioAssay: 2017 update
|
journal
|
November 2016 |
Comparison of multiple Amber force fields and development of improved protein backbone parameters
|
journal
|
November 2006 |
Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 1. Generalized Born
|
journal
|
April 2012 |
Biochemical and Structural Characterization of Cathepsin L-Processed Ebola Virus Glycoprotein: Implications for Viral Entry and Immunogenicity
|
journal
|
January 2010 |
Designed protein mimics of the Ebola virus glycoprotein GP2 α-helical bundle: Stability and pH effects
|
journal
|
August 2011 |
pH-REMD Simulations Indicate That the Catalytic Aspartates of HIV-1 Protease Exist Primarily in a Monoprotonated State
|
journal
|
October 2014 |
A new player in the puzzle of filovirus entry
|
journal
|
April 2012 |
Inhibition of Human Immunodeficiency Virus Type 1 Infectivity by the gp41 Core: Role of a Conserved Hydrophobic Cavity in Membrane Fusion
|
journal
|
October 1999 |
Effects of CCR5 and CD4 Cell Surface Concentrations on Infections by Macrophagetropic Isolates of Human Immunodeficiency Virus Type 1
|
journal
|
April 1998 |
Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity
|
journal
|
November 1995 |